Pfizer and BioNTech submit application to U.S. FDA for EUA of Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine in children under 5 years
On Dec. 5, 2022, Pfizer and BioNTech announced that the companies had submitted an application to the U.S….
Scientists revealed encouraging findings in first-in-human clinical trial evaluating HIV vaccine approach
On Dec. 2, 2022, in a multi-center collaboration led by Scripps Research, scientists announced they have achieved promising…
Highly pathogenic Avian influenza confirmed in Columbia County, Oregon.
On Dec. 1, 2022, the Oregon Department of Agriculture and the U.S. Department of Agricultureï¾’s Animal Plant Health…
Novavax updated EUA listing for Novavax Nuvaxovid COVID-19 vaccine as pimary series in adolescents and as booster in adults
On Nov. 29, 2022, Novavax announced that the World Health Organization had issued an updated Emergency Use Listing…
USDA broke ground on new Soil Research buildings in Auburn
On Nov. 28, 2022, the U.S. Department of Agricultureï¾’s Research Service, Auburn University’s College of Agriculture, and the…
WHO recommended new name for monkeypox disease
On Nov. 28, 2022, the WHO announced that following a series of consultations with global experts, it had…
Wolves emboldened by parasite more likely to lead pack
On Nov. 27, 2022, it was reported a parasite that infects up to one-third of people around the…
Researchers at Washington University in St. Louis announced finding diagnostic marker for deadly brain disease
On Nov. 24, 2022, researchers Kanta Horie and Chihiro Sato at the Tracy Family SILQ Center at Washington…
FDA approved first gene therapy to treat adults with Hemophilia B
On Nov. 22, 2022, the U.S. Food and Drug Administration approved the investigational gene therapy etranacogene dezaparvovec or…
FDA authorized Lucira COVID-19 & flu point-of-care test
On Nov. 22, 2022, the U.S. Food and Drug Administration issued an Emergency Use Authorization for the Lucira…
NIH awarded $12 million for antiviral therapeutic development
On Nov. 21, 2022, the National Institutes of Health awarded more than $12 million to three institutions for…
WHO to identify pathogens that could cause future outbreaks and pandemics
On Nov. 21, 2022, the WHO is launching a global scientific process to update the list of priority…
Pfizer and BioNTech report new data on Omicron BA.4/BA.5-adapted bivalent booster demonstrating improved immune response against Omicron sublineages
On Nov. 18, 2022, Pfizer and BioNTech announced results from an analysis examining the immune response induced by…
Novavax Nuvaxovid COVID-19 vaccine receives expanded authorization in Canada as a booster in adults
On Nov. 18, 2022, Novavax announced that Health Canada had granted expanded authorization for Nuvaxovidï¾™ (COVID-19 Vaccine (Recombinant…
U.S. pandemic death toll higher than in 20 peer countries
On Nov. 18, 2022, the Journal of the American Medical Association reported that the U.S. experienced high COVID-19…
Peru reported first severe bird-flu outbreak
On Nov. 18, 2022, the World Organisation for Animal Health announced that Peru had reported its first outbreak…
FDA approved first drug that can delay onset of Type 1 Diabetes
On Nov. 17, 2022, the U.S. Food and Drug Administration approved Tzield (teplizumab-mzwv) injection to delay the onset…
Pfizer and BioNTech advancd next-generation COVID-19 vaccine
On Nov. 16, 2022, Pfizer and BioNTech announced that the companies had initiated a Phase 1 study to…
CPRIT approved $12 million to bring top-flight cancer researchers to Lone Star State
On Nov. 16, 2022, the Cancer Prevention and Research Institute of Texas (CPRIT) approved $12 million in recruitment…
NIH researchers unlocked pattern of gene activity for ADHD
On Nov. 16, 2022, resarchers at the National Institutes of Health announced they had successfully identified differences in…
U.S. Preventive Services Task Force issued recommendation on screening for obstructive sleep apnea in adults
On Nov. 15, 2022, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
Roche received U.S. FDA Emergency Use Authorization for its high-throughput test to detect monkeypox virus
On Nov. 15, 2022, Roche announced that the U.S. Food and Drug Administration had granted Emergency Use Authorization…
FDA conditionally approved first drug to manage acute onset of pancreatitis in dogs Share Tweet Linkedin Email
On Nov. 15, 2022, the U.S. Food and Drug Administration conditionally approved Panoquell-CA1 (fuzapladib sodium for injection) for…
Moderna’s BA.4/BA.5 targeting bivalent booster, mRNA-1273.222, met primary endpoint of superiority against omicron variants
On Nov. 14, 2022, Moderna announced that both of Moderna’s bivalent Omicron-targeting booster candidates (mRNA-1273.214 and mRNA-1273.222) trigger…
Researchers identified a pathway by which chronic hyperglycaemia reduces cell function
On Nov. 14, 2022, researchers discovered the pathway by which chronic hyperglycaemia reduces β-cell function. Their data also…
Pfizer and BioNTech received positive CHMP opinion for Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine booster for children in EU
On Nov. 10, 2022, Pfizer and BioNTech announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine…
The Pearl Oyster genome was sequenced
On Nov. 10, 2022, researchers from the Okinawa Institute of Science and Technology (OIST), in collaboration with K….
University of Missouri study found Monkeypox mutations caused virus to spread rapidly, evade drugs and vaccines
On Nov. 9, 2022, researchers at the University of Missouri announced they had identified the highly prevalent, specific…
Novavax Nuvaxovid COVID-19 Vaccine authorized in the United Kingdom for use as a booster in adults
On Nov. 9, 2022, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
Novavax phase 3 COVID-19 Omicron trial supported continued and future use of prototype vaccine as a booster
On Nov. 8, 2022, Novavax announced topline results from its Phase 3 Boosting Trial for the SARS-CoV-2 rS…